instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin hypopigmentation'. | Stevens-Johnson syndrome and concurrent hand foot syndrome during treatment with capecitabine: A case report.
BACKGROUND
Capecitabine is used in combination with lapatinib as palliative treatment for human epidermal growth factor receptor 2 - positive metastatic breast cancer. The most frequently reported adverse event... | ADO-TRASTUZUMAB EMTANSINE, ANASTROZOLE, CAPECITABINE, EXEMESTANE, LAPATINIB, TRASTUZUMAB | DrugsGivenReaction | CC BY-NC | 34141791 | 19,517,579 | 2021-06-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Stevens-Johnson syndrome'. | Stevens-Johnson syndrome and concurrent hand foot syndrome during treatment with capecitabine: A case report.
BACKGROUND
Capecitabine is used in combination with lapatinib as palliative treatment for human epidermal growth factor receptor 2 - positive metastatic breast cancer. The most frequently reported adverse event... | ADO-TRASTUZUMAB EMTANSINE, ANASTROZOLE, CAPECITABINE, EXEMESTANE, LAPATINIB, TRASTUZUMAB | DrugsGivenReaction | CC BY-NC | 34141791 | 19,517,579 | 2021-06-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Stevens-Johnson syndrome and concurrent hand foot syndrome during treatment with capecitabine: A case report.
BACKGROUND
Capecitabine is used in combination with lapatinib as palliative treatment for human epidermal growth factor receptor 2 - positive metastatic breast cancer. The most frequently reported adverse event... | ADO-TRASTUZUMAB EMTANSINE, ANASTROZOLE, CAPECITABINE, EXEMESTANE, LAPATINIB, TRASTUZUMAB | DrugsGivenReaction | CC BY-NC | 34141791 | 19,517,579 | 2021-06-16 |
What was the administration route of drug 'CAPECITABINE'? | Stevens-Johnson syndrome and concurrent hand foot syndrome during treatment with capecitabine: A case report.
BACKGROUND
Capecitabine is used in combination with lapatinib as palliative treatment for human epidermal growth factor receptor 2 - positive metastatic breast cancer. The most frequently reported adverse event... | Oral | DrugAdministrationRoute | CC BY-NC | 34141791 | 19,517,579 | 2021-06-16 |
What was the outcome of reaction 'Palmar-plantar erythrodysaesthesia syndrome'? | Stevens-Johnson syndrome and concurrent hand foot syndrome during treatment with capecitabine: A case report.
BACKGROUND
Capecitabine is used in combination with lapatinib as palliative treatment for human epidermal growth factor receptor 2 - positive metastatic breast cancer. The most frequently reported adverse event... | Recovered | ReactionOutcome | CC BY-NC | 34141791 | 19,517,579 | 2021-06-16 |
What was the outcome of reaction 'Stevens-Johnson syndrome'? | Stevens-Johnson syndrome and concurrent hand foot syndrome during treatment with capecitabine: A case report.
BACKGROUND
Capecitabine is used in combination with lapatinib as palliative treatment for human epidermal growth factor receptor 2 - positive metastatic breast cancer. The most frequently reported adverse event... | Recovered | ReactionOutcome | CC BY-NC | 34141791 | 19,517,579 | 2021-06-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Acute myocardial infarction in twin pregnancy after assisted reproduction: A case report.
BACKGROUND
Acute myocardial infarction (AMI) during pregnancy is rare, especially in twin pregnancy, and it can endanger the lives of the mother and children. Except for conventional cardiovascular risk factors, pregnancy and assi... | ASPIRIN, ENOXAPARIN SODIUM, ISOSORBIDE MONONITRATE | DrugsGivenReaction | CC BY-NC | 34141793 | 20,368,728 | 2021-06-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Live birth'. | Acute myocardial infarction in twin pregnancy after assisted reproduction: A case report.
BACKGROUND
Acute myocardial infarction (AMI) during pregnancy is rare, especially in twin pregnancy, and it can endanger the lives of the mother and children. Except for conventional cardiovascular risk factors, pregnancy and assi... | ASPIRIN, ENOXAPARIN SODIUM, ISOSORBIDE MONONITRATE | DrugsGivenReaction | CC BY-NC | 34141793 | 20,368,728 | 2021-06-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Premature delivery'. | Acute myocardial infarction in twin pregnancy after assisted reproduction: A case report.
BACKGROUND
Acute myocardial infarction (AMI) during pregnancy is rare, especially in twin pregnancy, and it can endanger the lives of the mother and children. Except for conventional cardiovascular risk factors, pregnancy and assi... | ASPIRIN, BETAHISTINE MESILATE, DEXAMETHASONE, ENOXAPARIN, MAGNESIUM SULFATE, MORPHINE, NIFEDIPINE, ONDANSETRON, SODIUM CHLORIDE | DrugsGivenReaction | CC BY-NC | 34141793 | 20,365,835 | 2021-06-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Twin pregnancy'. | Acute myocardial infarction in twin pregnancy after assisted reproduction: A case report.
BACKGROUND
Acute myocardial infarction (AMI) during pregnancy is rare, especially in twin pregnancy, and it can endanger the lives of the mother and children. Except for conventional cardiovascular risk factors, pregnancy and assi... | ASPIRIN, BETAHISTINE MESILATE, DEXAMETHASONE, ENOXAPARIN, MAGNESIUM SULFATE, MORPHINE, NIFEDIPINE, ONDANSETRON, SODIUM CHLORIDE | DrugsGivenReaction | CC BY-NC | 34141793 | 20,365,835 | 2021-06-16 |
What was the administration route of drug 'ASPIRIN'? | Acute myocardial infarction in twin pregnancy after assisted reproduction: A case report.
BACKGROUND
Acute myocardial infarction (AMI) during pregnancy is rare, especially in twin pregnancy, and it can endanger the lives of the mother and children. Except for conventional cardiovascular risk factors, pregnancy and assi... | Transplacental | DrugAdministrationRoute | CC BY-NC | 34141793 | 20,368,938 | 2021-06-16 |
What was the administration route of drug 'BETAHISTINE MESILATE'? | Acute myocardial infarction in twin pregnancy after assisted reproduction: A case report.
BACKGROUND
Acute myocardial infarction (AMI) during pregnancy is rare, especially in twin pregnancy, and it can endanger the lives of the mother and children. Except for conventional cardiovascular risk factors, pregnancy and assi... | Transplacental | DrugAdministrationRoute | CC BY-NC | 34141793 | 20,368,938 | 2021-06-16 |
What was the administration route of drug 'DEXAMETHASONE'? | Acute myocardial infarction in twin pregnancy after assisted reproduction: A case report.
BACKGROUND
Acute myocardial infarction (AMI) during pregnancy is rare, especially in twin pregnancy, and it can endanger the lives of the mother and children. Except for conventional cardiovascular risk factors, pregnancy and assi... | Transplacental | DrugAdministrationRoute | CC BY-NC | 34141793 | 20,368,938 | 2021-06-16 |
What was the administration route of drug 'ISOSORBIDE MONONITRATE'? | Acute myocardial infarction in twin pregnancy after assisted reproduction: A case report.
BACKGROUND
Acute myocardial infarction (AMI) during pregnancy is rare, especially in twin pregnancy, and it can endanger the lives of the mother and children. Except for conventional cardiovascular risk factors, pregnancy and assi... | Transplacental | DrugAdministrationRoute | CC BY-NC | 34141793 | 20,368,938 | 2021-06-16 |
What was the administration route of drug 'MAGNESIUM SULFATE'? | Acute myocardial infarction in twin pregnancy after assisted reproduction: A case report.
BACKGROUND
Acute myocardial infarction (AMI) during pregnancy is rare, especially in twin pregnancy, and it can endanger the lives of the mother and children. Except for conventional cardiovascular risk factors, pregnancy and assi... | Transplacental | DrugAdministrationRoute | CC BY-NC | 34141793 | 20,368,938 | 2021-06-16 |
What was the administration route of drug 'NIFEDIPINE'? | Acute myocardial infarction in twin pregnancy after assisted reproduction: A case report.
BACKGROUND
Acute myocardial infarction (AMI) during pregnancy is rare, especially in twin pregnancy, and it can endanger the lives of the mother and children. Except for conventional cardiovascular risk factors, pregnancy and assi... | Transplacental | DrugAdministrationRoute | CC BY-NC | 34141793 | 20,368,938 | 2021-06-16 |
What was the administration route of drug 'ONDANSETRON'? | Acute myocardial infarction in twin pregnancy after assisted reproduction: A case report.
BACKGROUND
Acute myocardial infarction (AMI) during pregnancy is rare, especially in twin pregnancy, and it can endanger the lives of the mother and children. Except for conventional cardiovascular risk factors, pregnancy and assi... | Transplacental | DrugAdministrationRoute | CC BY-NC | 34141793 | 20,368,938 | 2021-06-16 |
What was the administration route of drug 'PROGESTERONE'? | Acute myocardial infarction in twin pregnancy after assisted reproduction: A case report.
BACKGROUND
Acute myocardial infarction (AMI) during pregnancy is rare, especially in twin pregnancy, and it can endanger the lives of the mother and children. Except for conventional cardiovascular risk factors, pregnancy and assi... | Transplacental | DrugAdministrationRoute | CC BY-NC | 34141793 | 20,368,938 | 2021-06-16 |
What was the administration route of drug 'SODIUM CHLORIDE'? | Acute myocardial infarction in twin pregnancy after assisted reproduction: A case report.
BACKGROUND
Acute myocardial infarction (AMI) during pregnancy is rare, especially in twin pregnancy, and it can endanger the lives of the mother and children. Except for conventional cardiovascular risk factors, pregnancy and assi... | Transplacental | DrugAdministrationRoute | CC BY-NC | 34141793 | 20,368,938 | 2021-06-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute hepatic failure'. | Acute liver failure with thrombotic microangiopathy due to sodium valproate toxicity: A case report.
BACKGROUND
Sodium valproate is widely used in the treatment of epilepsy in clinical practice. Most adverse reactions to sodium valproate are mild and reversible, while serious idiosyncratic side effects are becoming app... | VALPROIC ACID | DrugsGivenReaction | CC BY-NC | 34141795 | 19,492,576 | 2021-06-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Acute liver failure with thrombotic microangiopathy due to sodium valproate toxicity: A case report.
BACKGROUND
Sodium valproate is widely used in the treatment of epilepsy in clinical practice. Most adverse reactions to sodium valproate are mild and reversible, while serious idiosyncratic side effects are becoming app... | METHYLPREDNISOLONE, VALPROATE SODIUM | DrugsGivenReaction | CC BY-NC | 34141795 | 19,509,544 | 2021-06-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic failure'. | Acute liver failure with thrombotic microangiopathy due to sodium valproate toxicity: A case report.
BACKGROUND
Sodium valproate is widely used in the treatment of epilepsy in clinical practice. Most adverse reactions to sodium valproate are mild and reversible, while serious idiosyncratic side effects are becoming app... | DIVALPROEX SODIUM | DrugsGivenReaction | CC BY-NC | 34141795 | 19,477,100 | 2021-06-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Acute liver failure with thrombotic microangiopathy due to sodium valproate toxicity: A case report.
BACKGROUND
Sodium valproate is widely used in the treatment of epilepsy in clinical practice. Most adverse reactions to sodium valproate are mild and reversible, while serious idiosyncratic side effects are becoming app... | METHYLPREDNISOLONE, VALPROATE SODIUM | DrugsGivenReaction | CC BY-NC | 34141795 | 19,509,544 | 2021-06-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal impairment'. | Acute liver failure with thrombotic microangiopathy due to sodium valproate toxicity: A case report.
BACKGROUND
Sodium valproate is widely used in the treatment of epilepsy in clinical practice. Most adverse reactions to sodium valproate are mild and reversible, while serious idiosyncratic side effects are becoming app... | DIVALPROEX SODIUM | DrugsGivenReaction | CC BY-NC | 34141795 | 19,477,100 | 2021-06-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | Acute liver failure with thrombotic microangiopathy due to sodium valproate toxicity: A case report.
BACKGROUND
Sodium valproate is widely used in the treatment of epilepsy in clinical practice. Most adverse reactions to sodium valproate are mild and reversible, while serious idiosyncratic side effects are becoming app... | DIVALPROEX SODIUM | DrugsGivenReaction | CC BY-NC | 34141795 | 19,477,100 | 2021-06-16 |
What was the dosage of drug 'CEFTRIAXONE'? | Acute liver failure with thrombotic microangiopathy due to sodium valproate toxicity: A case report.
BACKGROUND
Sodium valproate is widely used in the treatment of epilepsy in clinical practice. Most adverse reactions to sodium valproate are mild and reversible, while serious idiosyncratic side effects are becoming app... | 2 g (grams). | DrugDosage | CC BY-NC | 34141795 | 19,481,705 | 2021-06-16 |
What was the outcome of reaction 'Acute hepatic failure'? | Acute liver failure with thrombotic microangiopathy due to sodium valproate toxicity: A case report.
BACKGROUND
Sodium valproate is widely used in the treatment of epilepsy in clinical practice. Most adverse reactions to sodium valproate are mild and reversible, while serious idiosyncratic side effects are becoming app... | Fatal | ReactionOutcome | CC BY-NC | 34141795 | 19,492,576 | 2021-06-16 |
What was the outcome of reaction 'Brain oedema'? | Acute liver failure with thrombotic microangiopathy due to sodium valproate toxicity: A case report.
BACKGROUND
Sodium valproate is widely used in the treatment of epilepsy in clinical practice. Most adverse reactions to sodium valproate are mild and reversible, while serious idiosyncratic side effects are becoming app... | Fatal | ReactionOutcome | CC BY-NC | 34141795 | 19,477,100 | 2021-06-16 |
What was the outcome of reaction 'Coma'? | Acute liver failure with thrombotic microangiopathy due to sodium valproate toxicity: A case report.
BACKGROUND
Sodium valproate is widely used in the treatment of epilepsy in clinical practice. Most adverse reactions to sodium valproate are mild and reversible, while serious idiosyncratic side effects are becoming app... | Fatal | ReactionOutcome | CC BY-NC | 34141795 | 19,477,100 | 2021-06-16 |
What was the outcome of reaction 'Drug ineffective'? | Acute liver failure with thrombotic microangiopathy due to sodium valproate toxicity: A case report.
BACKGROUND
Sodium valproate is widely used in the treatment of epilepsy in clinical practice. Most adverse reactions to sodium valproate are mild and reversible, while serious idiosyncratic side effects are becoming app... | Fatal | ReactionOutcome | CC BY-NC | 34141795 | 19,509,544 | 2021-06-16 |
What was the outcome of reaction 'Drug-induced liver injury'? | Acute liver failure with thrombotic microangiopathy due to sodium valproate toxicity: A case report.
BACKGROUND
Sodium valproate is widely used in the treatment of epilepsy in clinical practice. Most adverse reactions to sodium valproate are mild and reversible, while serious idiosyncratic side effects are becoming app... | Fatal | ReactionOutcome | CC BY-NC | 34141795 | 19,477,100 | 2021-06-16 |
What was the outcome of reaction 'Headache'? | Acute liver failure with thrombotic microangiopathy due to sodium valproate toxicity: A case report.
BACKGROUND
Sodium valproate is widely used in the treatment of epilepsy in clinical practice. Most adverse reactions to sodium valproate are mild and reversible, while serious idiosyncratic side effects are becoming app... | Fatal | ReactionOutcome | CC BY-NC | 34141795 | 19,477,100 | 2021-06-16 |
What was the outcome of reaction 'Hepatic failure'? | Acute liver failure with thrombotic microangiopathy due to sodium valproate toxicity: A case report.
BACKGROUND
Sodium valproate is widely used in the treatment of epilepsy in clinical practice. Most adverse reactions to sodium valproate are mild and reversible, while serious idiosyncratic side effects are becoming app... | Fatal | ReactionOutcome | CC BY-NC | 34141795 | 19,477,100 | 2021-06-16 |
What was the outcome of reaction 'Renal impairment'? | Acute liver failure with thrombotic microangiopathy due to sodium valproate toxicity: A case report.
BACKGROUND
Sodium valproate is widely used in the treatment of epilepsy in clinical practice. Most adverse reactions to sodium valproate are mild and reversible, while serious idiosyncratic side effects are becoming app... | Fatal | ReactionOutcome | CC BY-NC | 34141795 | 19,477,100 | 2021-06-16 |
What was the outcome of reaction 'Thrombotic microangiopathy'? | Acute liver failure with thrombotic microangiopathy due to sodium valproate toxicity: A case report.
BACKGROUND
Sodium valproate is widely used in the treatment of epilepsy in clinical practice. Most adverse reactions to sodium valproate are mild and reversible, while serious idiosyncratic side effects are becoming app... | Fatal | ReactionOutcome | CC BY-NC | 34141795 | 19,492,576 | 2021-06-16 |
What was the outcome of reaction 'Toxicity to various agents'? | Acute liver failure with thrombotic microangiopathy due to sodium valproate toxicity: A case report.
BACKGROUND
Sodium valproate is widely used in the treatment of epilepsy in clinical practice. Most adverse reactions to sodium valproate are mild and reversible, while serious idiosyncratic side effects are becoming app... | Fatal | ReactionOutcome | CC BY-NC | 34141795 | 19,477,100 | 2021-06-16 |
What was the outcome of reaction 'Vomiting'? | Acute liver failure with thrombotic microangiopathy due to sodium valproate toxicity: A case report.
BACKGROUND
Sodium valproate is widely used in the treatment of epilepsy in clinical practice. Most adverse reactions to sodium valproate are mild and reversible, while serious idiosyncratic side effects are becoming app... | Fatal | ReactionOutcome | CC BY-NC | 34141795 | 19,477,100 | 2021-06-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal pain'. | Minimally invasive surgery for glycogen storage disease combined with inflammatory bowel disease: A case report.
BACKGROUND
Inflammatory bowel disease (IBD) is rare in patients with glycogen storage disease (GSD). In GSD patients, a decrease in the number of neutrophils leads to prolonged intestinal infection, leading ... | ADALIMUMAB, MESALAMINE, PREDNISONE | DrugsGivenReaction | CC BY-NC | 34141799 | 19,497,371 | 2021-06-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | Minimally invasive surgery for glycogen storage disease combined with inflammatory bowel disease: A case report.
BACKGROUND
Inflammatory bowel disease (IBD) is rare in patients with glycogen storage disease (GSD). In GSD patients, a decrease in the number of neutrophils leads to prolonged intestinal infection, leading ... | ADALIMUMAB, MESALAMINE, PREDNISONE | DrugsGivenReaction | CC BY-NC | 34141799 | 19,497,371 | 2021-06-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Minimally invasive surgery for glycogen storage disease combined with inflammatory bowel disease: A case report.
BACKGROUND
Inflammatory bowel disease (IBD) is rare in patients with glycogen storage disease (GSD). In GSD patients, a decrease in the number of neutrophils leads to prolonged intestinal infection, leading ... | ADALIMUMAB, MESALAMINE, PREDNISONE | DrugsGivenReaction | CC BY-NC | 34141799 | 19,469,374 | 2021-06-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dyschezia'. | Minimally invasive surgery for glycogen storage disease combined with inflammatory bowel disease: A case report.
BACKGROUND
Inflammatory bowel disease (IBD) is rare in patients with glycogen storage disease (GSD). In GSD patients, a decrease in the number of neutrophils leads to prolonged intestinal infection, leading ... | ADALIMUMAB, MESALAMINE, PREDNISONE | DrugsGivenReaction | CC BY-NC | 34141799 | 19,497,371 | 2021-06-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ileus'. | Minimally invasive surgery for glycogen storage disease combined with inflammatory bowel disease: A case report.
BACKGROUND
Inflammatory bowel disease (IBD) is rare in patients with glycogen storage disease (GSD). In GSD patients, a decrease in the number of neutrophils leads to prolonged intestinal infection, leading ... | ADALIMUMAB, MESALAMINE, PREDNISONE | DrugsGivenReaction | CC BY-NC | 34141799 | 19,469,374 | 2021-06-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Large intestinal stenosis'. | Minimally invasive surgery for glycogen storage disease combined with inflammatory bowel disease: A case report.
BACKGROUND
Inflammatory bowel disease (IBD) is rare in patients with glycogen storage disease (GSD). In GSD patients, a decrease in the number of neutrophils leads to prolonged intestinal infection, leading ... | ADALIMUMAB, MESALAMINE, PREDNISONE | DrugsGivenReaction | CC BY-NC | 34141799 | 19,469,374 | 2021-06-16 |
What is the weight of the patient? | Minimally invasive surgery for glycogen storage disease combined with inflammatory bowel disease: A case report.
BACKGROUND
Inflammatory bowel disease (IBD) is rare in patients with glycogen storage disease (GSD). In GSD patients, a decrease in the number of neutrophils leads to prolonged intestinal infection, leading ... | 44 kg. | Weight | CC BY-NC | 34141799 | 19,497,371 | 2021-06-16 |
What was the administration route of drug 'ADALIMUMAB'? | Minimally invasive surgery for glycogen storage disease combined with inflammatory bowel disease: A case report.
BACKGROUND
Inflammatory bowel disease (IBD) is rare in patients with glycogen storage disease (GSD). In GSD patients, a decrease in the number of neutrophils leads to prolonged intestinal infection, leading ... | Subcutaneous | DrugAdministrationRoute | CC BY-NC | 34141799 | 19,469,374 | 2021-06-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | A Novel Dosing Strategy of Ceftolozane/Tazobactam in a Patient Receiving Intermittent Hemodialysis.
We describe the case of a 54-year-old male receiving intermittent hemodialysis (iHD) who was found to have Pseudomonas aeruginosa bacteremia secondary to osteomyelitis of the calcaneus bone. The patient was clinically cu... | CEFTAZIDIME, CEFTOLOZANE SULFATE\TAZOBACTAM SODIUM, CIPROFLOXACIN, ERTAPENEM SODIUM, MEROPENEM, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM | DrugsGivenReaction | CC BY-NC-ND | 34141819 | 20,176,188 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | A Novel Dosing Strategy of Ceftolozane/Tazobactam in a Patient Receiving Intermittent Hemodialysis.
We describe the case of a 54-year-old male receiving intermittent hemodialysis (iHD) who was found to have Pseudomonas aeruginosa bacteremia secondary to osteomyelitis of the calcaneus bone. The patient was clinically cu... | ERTAPENEM SODIUM | DrugsGivenReaction | CC BY-NC-ND | 34141819 | 20,176,584 | 2021-06 |
What is the weight of the patient? | A Novel Dosing Strategy of Ceftolozane/Tazobactam in a Patient Receiving Intermittent Hemodialysis.
We describe the case of a 54-year-old male receiving intermittent hemodialysis (iHD) who was found to have Pseudomonas aeruginosa bacteremia secondary to osteomyelitis of the calcaneus bone. The patient was clinically cu... | 101 kg. | Weight | CC BY-NC-ND | 34141819 | 20,176,584 | 2021-06 |
What was the administration route of drug 'CEFTOLOZANE SULFATE\TAZOBACTAM SODIUM'? | A Novel Dosing Strategy of Ceftolozane/Tazobactam in a Patient Receiving Intermittent Hemodialysis.
We describe the case of a 54-year-old male receiving intermittent hemodialysis (iHD) who was found to have Pseudomonas aeruginosa bacteremia secondary to osteomyelitis of the calcaneus bone. The patient was clinically cu... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34141819 | 20,176,188 | 2021-06 |
What was the dosage of drug 'ERTAPENEM SODIUM'? | A Novel Dosing Strategy of Ceftolozane/Tazobactam in a Patient Receiving Intermittent Hemodialysis.
We describe the case of a 54-year-old male receiving intermittent hemodialysis (iHD) who was found to have Pseudomonas aeruginosa bacteremia secondary to osteomyelitis of the calcaneus bone. The patient was clinically cu... | UNK; DURATION OF REGIMEN: 7 DAYS | DrugDosageText | CC BY-NC-ND | 34141819 | 20,176,584 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Levetiracetam-associated irritability and potential role of vitamin B6 use in veterans with epilepsy.
Levetiracetam, a commonly prescribed antiseizure medication (ASM), may cause irritability, depression, and anger. The mechanisms underlying these behavioral effects and individual risk factors remain unknown. Mitigatio... | LEVETIRACETAM, PYRIDOXINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34142077 | 20,289,579 | 2021 |
What was the outcome of reaction 'Death'? | Levetiracetam-associated irritability and potential role of vitamin B6 use in veterans with epilepsy.
Levetiracetam, a commonly prescribed antiseizure medication (ASM), may cause irritability, depression, and anger. The mechanisms underlying these behavioral effects and individual risk factors remain unknown. Mitigatio... | Fatal | ReactionOutcome | CC BY-NC-ND | 34142077 | 20,289,579 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anticonvulsant drug level below therapeutic'. | Weekly methotrexate may reduce valproate levels causing relapse of genetic generalized epilepsy.
•Seizures have been observed in epilepsy patients receiving high dose intravenous or intrathecal Methotrexate (Mtx) therapy for the treatment of leukemias, due to reduction in valproic acid (VPA) levels.•Prolonged low dose ... | METHOTREXATE SODIUM, VALPROIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34142078 | 19,593,645 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug level decreased'. | Weekly methotrexate may reduce valproate levels causing relapse of genetic generalized epilepsy.
•Seizures have been observed in epilepsy patients receiving high dose intravenous or intrathecal Methotrexate (Mtx) therapy for the treatment of leukemias, due to reduction in valproic acid (VPA) levels.•Prolonged low dose ... | METHOTREXATE, VALPROIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34142078 | 19,492,578 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Epilepsy'. | Weekly methotrexate may reduce valproate levels causing relapse of genetic generalized epilepsy.
•Seizures have been observed in epilepsy patients receiving high dose intravenous or intrathecal Methotrexate (Mtx) therapy for the treatment of leukemias, due to reduction in valproic acid (VPA) levels.•Prolonged low dose ... | METHOTREXATE, VALPROIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34142078 | 19,492,578 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neurotoxicity'. | Weekly methotrexate may reduce valproate levels causing relapse of genetic generalized epilepsy.
•Seizures have been observed in epilepsy patients receiving high dose intravenous or intrathecal Methotrexate (Mtx) therapy for the treatment of leukemias, due to reduction in valproic acid (VPA) levels.•Prolonged low dose ... | METHOTREXATE SODIUM, VALPROIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34142078 | 19,593,645 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Petit mal epilepsy'. | Weekly methotrexate may reduce valproate levels causing relapse of genetic generalized epilepsy.
•Seizures have been observed in epilepsy patients receiving high dose intravenous or intrathecal Methotrexate (Mtx) therapy for the treatment of leukemias, due to reduction in valproic acid (VPA) levels.•Prolonged low dose ... | METHOTREXATE, VALPROIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34142078 | 19,577,474 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Seizure'. | Weekly methotrexate may reduce valproate levels causing relapse of genetic generalized epilepsy.
•Seizures have been observed in epilepsy patients receiving high dose intravenous or intrathecal Methotrexate (Mtx) therapy for the treatment of leukemias, due to reduction in valproic acid (VPA) levels.•Prolonged low dose ... | METHOTREXATE SODIUM, VALPROIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34142078 | 19,593,645 | 2021 |
What was the outcome of reaction 'Anticonvulsant drug level below therapeutic'? | Weekly methotrexate may reduce valproate levels causing relapse of genetic generalized epilepsy.
•Seizures have been observed in epilepsy patients receiving high dose intravenous or intrathecal Methotrexate (Mtx) therapy for the treatment of leukemias, due to reduction in valproic acid (VPA) levels.•Prolonged low dose ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34142078 | 19,593,645 | 2021 |
What was the outcome of reaction 'Drug interaction'? | Weekly methotrexate may reduce valproate levels causing relapse of genetic generalized epilepsy.
•Seizures have been observed in epilepsy patients receiving high dose intravenous or intrathecal Methotrexate (Mtx) therapy for the treatment of leukemias, due to reduction in valproic acid (VPA) levels.•Prolonged low dose ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34142078 | 19,577,474 | 2021 |
What was the outcome of reaction 'Epilepsy'? | Weekly methotrexate may reduce valproate levels causing relapse of genetic generalized epilepsy.
•Seizures have been observed in epilepsy patients receiving high dose intravenous or intrathecal Methotrexate (Mtx) therapy for the treatment of leukemias, due to reduction in valproic acid (VPA) levels.•Prolonged low dose ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34142078 | 19,492,578 | 2021 |
What was the outcome of reaction 'Neurotoxicity'? | Weekly methotrexate may reduce valproate levels causing relapse of genetic generalized epilepsy.
•Seizures have been observed in epilepsy patients receiving high dose intravenous or intrathecal Methotrexate (Mtx) therapy for the treatment of leukemias, due to reduction in valproic acid (VPA) levels.•Prolonged low dose ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34142078 | 19,593,645 | 2021 |
What was the outcome of reaction 'Petit mal epilepsy'? | Weekly methotrexate may reduce valproate levels causing relapse of genetic generalized epilepsy.
•Seizures have been observed in epilepsy patients receiving high dose intravenous or intrathecal Methotrexate (Mtx) therapy for the treatment of leukemias, due to reduction in valproic acid (VPA) levels.•Prolonged low dose ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34142078 | 19,577,474 | 2021 |
What was the outcome of reaction 'Seizure'? | Weekly methotrexate may reduce valproate levels causing relapse of genetic generalized epilepsy.
•Seizures have been observed in epilepsy patients receiving high dose intravenous or intrathecal Methotrexate (Mtx) therapy for the treatment of leukemias, due to reduction in valproic acid (VPA) levels.•Prolonged low dose ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34142078 | 19,593,645 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vasoplegia syndrome'. | Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass.
BACKGROUND Cardiac vasoplegic syndrome is a form of vasodilatory shock characterized by profound vasodilation and low systemic vascular resistance, which results in significant hypotension despite... | CALCIUM CHLORIDE, EPINEPHRINE, NOREPINEPHRINE, PHENYLEPHRINE HYDROCHLORIDE, VASOPRESSIN | DrugsGivenReaction | CC BY-NC-ND | 34143764 | 19,568,909 | 2021-06-18 |
What was the dosage of drug 'PROPOFOL'? | Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass.
BACKGROUND Cardiac vasoplegic syndrome is a form of vasodilatory shock characterized by profound vasodilation and low systemic vascular resistance, which results in significant hypotension despite... | 20 MILLIGRAM | DrugDosageText | CC BY-NC-ND | 34143764 | 19,680,713 | 2021-06-18 |
What was the outcome of reaction 'Vasoplegia syndrome'? | Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass.
BACKGROUND Cardiac vasoplegic syndrome is a form of vasodilatory shock characterized by profound vasodilation and low systemic vascular resistance, which results in significant hypotension despite... | Recovered | ReactionOutcome | CC BY-NC-ND | 34143764 | 19,568,909 | 2021-06-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dermatitis'. | Unexpected toxicity of CDK4/6 inhibitor palbociclib and radiotherapy.
BACKGROUND
Cyclin-dependent kinase (CDK) 4/6 inhibitors have recently been approved for the treatment of hormone receptor-positive and HER2-negative metastatic breast cancer in association with endocrine therapy in postmenopausal women. Data on the i... | FULVESTRANT, MORPHINE, PALBOCICLIB, PREDNISONE | DrugsGivenReaction | CC BY | 34145976 | 20,892,716 | 2021-06-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Unexpected toxicity of CDK4/6 inhibitor palbociclib and radiotherapy.
BACKGROUND
Cyclin-dependent kinase (CDK) 4/6 inhibitors have recently been approved for the treatment of hormone receptor-positive and HER2-negative metastatic breast cancer in association with endocrine therapy in postmenopausal women. Data on the i... | PALBOCICLIB | DrugsGivenReaction | CC BY | 34145976 | 19,527,906 | 2021-06-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dysphagia'. | Unexpected toxicity of CDK4/6 inhibitor palbociclib and radiotherapy.
BACKGROUND
Cyclin-dependent kinase (CDK) 4/6 inhibitors have recently been approved for the treatment of hormone receptor-positive and HER2-negative metastatic breast cancer in association with endocrine therapy in postmenopausal women. Data on the i... | FULVESTRANT, PALBOCICLIB | DrugsGivenReaction | CC BY | 34145976 | 19,527,908 | 2021-06-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Enterocolitis'. | Unexpected toxicity of CDK4/6 inhibitor palbociclib and radiotherapy.
BACKGROUND
Cyclin-dependent kinase (CDK) 4/6 inhibitors have recently been approved for the treatment of hormone receptor-positive and HER2-negative metastatic breast cancer in association with endocrine therapy in postmenopausal women. Data on the i... | PALBOCICLIB | DrugsGivenReaction | CC BY | 34145976 | 19,527,906 | 2021-06-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oedema'. | Unexpected toxicity of CDK4/6 inhibitor palbociclib and radiotherapy.
BACKGROUND
Cyclin-dependent kinase (CDK) 4/6 inhibitors have recently been approved for the treatment of hormone receptor-positive and HER2-negative metastatic breast cancer in association with endocrine therapy in postmenopausal women. Data on the i... | FULVESTRANT, MORPHINE, PALBOCICLIB, PREDNISONE | DrugsGivenReaction | CC BY | 34145976 | 20,892,716 | 2021-06-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oesophageal ulcer'. | Unexpected toxicity of CDK4/6 inhibitor palbociclib and radiotherapy.
BACKGROUND
Cyclin-dependent kinase (CDK) 4/6 inhibitors have recently been approved for the treatment of hormone receptor-positive and HER2-negative metastatic breast cancer in association with endocrine therapy in postmenopausal women. Data on the i... | FULVESTRANT, PALBOCICLIB | DrugsGivenReaction | CC BY | 34145976 | 19,527,908 | 2021-06-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pain'. | Unexpected toxicity of CDK4/6 inhibitor palbociclib and radiotherapy.
BACKGROUND
Cyclin-dependent kinase (CDK) 4/6 inhibitors have recently been approved for the treatment of hormone receptor-positive and HER2-negative metastatic breast cancer in association with endocrine therapy in postmenopausal women. Data on the i... | FULVESTRANT, MORPHINE, PALBOCICLIB, PREDNISONE | DrugsGivenReaction | CC BY | 34145976 | 20,892,716 | 2021-06-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Radiation interaction'. | Unexpected toxicity of CDK4/6 inhibitor palbociclib and radiotherapy.
BACKGROUND
Cyclin-dependent kinase (CDK) 4/6 inhibitors have recently been approved for the treatment of hormone receptor-positive and HER2-negative metastatic breast cancer in association with endocrine therapy in postmenopausal women. Data on the i... | PALBOCICLIB | DrugsGivenReaction | CC BY | 34145976 | 19,527,906 | 2021-06-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Unexpected toxicity of CDK4/6 inhibitor palbociclib and radiotherapy.
BACKGROUND
Cyclin-dependent kinase (CDK) 4/6 inhibitors have recently been approved for the treatment of hormone receptor-positive and HER2-negative metastatic breast cancer in association with endocrine therapy in postmenopausal women. Data on the i... | FULVESTRANT, MORPHINE, PALBOCICLIB, PREDNISONE | DrugsGivenReaction | CC BY | 34145976 | 20,892,716 | 2021-06-18 |
What was the administration route of drug 'MORPHINE'? | Unexpected toxicity of CDK4/6 inhibitor palbociclib and radiotherapy.
BACKGROUND
Cyclin-dependent kinase (CDK) 4/6 inhibitors have recently been approved for the treatment of hormone receptor-positive and HER2-negative metastatic breast cancer in association with endocrine therapy in postmenopausal women. Data on the i... | Oral | DrugAdministrationRoute | CC BY | 34145976 | 20,892,716 | 2021-06-18 |
What was the dosage of drug 'PALBOCICLIB'? | Unexpected toxicity of CDK4/6 inhibitor palbociclib and radiotherapy.
BACKGROUND
Cyclin-dependent kinase (CDK) 4/6 inhibitors have recently been approved for the treatment of hormone receptor-positive and HER2-negative metastatic breast cancer in association with endocrine therapy in postmenopausal women. Data on the i... | UNK, DAILY | DrugDosageText | CC BY | 34145976 | 19,527,908 | 2021-06-18 |
What was the outcome of reaction 'Dysphagia'? | Unexpected toxicity of CDK4/6 inhibitor palbociclib and radiotherapy.
BACKGROUND
Cyclin-dependent kinase (CDK) 4/6 inhibitors have recently been approved for the treatment of hormone receptor-positive and HER2-negative metastatic breast cancer in association with endocrine therapy in postmenopausal women. Data on the i... | Recovering | ReactionOutcome | CC BY | 34145976 | 19,527,908 | 2021-06-18 |
What was the outcome of reaction 'Enterocolitis'? | Unexpected toxicity of CDK4/6 inhibitor palbociclib and radiotherapy.
BACKGROUND
Cyclin-dependent kinase (CDK) 4/6 inhibitors have recently been approved for the treatment of hormone receptor-positive and HER2-negative metastatic breast cancer in association with endocrine therapy in postmenopausal women. Data on the i... | Not recovered | ReactionOutcome | CC BY | 34145976 | 19,527,906 | 2021-06-18 |
What was the outcome of reaction 'Oesophageal ulcer'? | Unexpected toxicity of CDK4/6 inhibitor palbociclib and radiotherapy.
BACKGROUND
Cyclin-dependent kinase (CDK) 4/6 inhibitors have recently been approved for the treatment of hormone receptor-positive and HER2-negative metastatic breast cancer in association with endocrine therapy in postmenopausal women. Data on the i... | Recovering | ReactionOutcome | CC BY | 34145976 | 19,527,908 | 2021-06-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Treatment Outcome of Nab-paclitaxel Plus Gemcitabine for Leptomeningeal Carcinomatosis from Pancreatic Ductal Adenocarcinoma: An Autopsy Case Report.
A 57-year-old woman with a sudden-onset seizure was hospitalized. Brain magnetic resonance imaging findings led to a suspicion of leptomeningeal carcinomatosis (LMC) with... | GEMCITABINE, PACLITAXEL | DrugsGivenReaction | CC BY-NC-ND | 34148945 | 19,505,629 | 2021-12-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Treatment Outcome of Nab-paclitaxel Plus Gemcitabine for Leptomeningeal Carcinomatosis from Pancreatic Ductal Adenocarcinoma: An Autopsy Case Report.
A 57-year-old woman with a sudden-onset seizure was hospitalized. Brain magnetic resonance imaging findings led to a suspicion of leptomeningeal carcinomatosis (LMC) with... | GEMCITABINE, PACLITAXEL | DrugsGivenReaction | CC BY-NC-ND | 34148945 | 19,505,629 | 2021-12-01 |
What was the administration route of drug 'GEMCITABINE'? | Treatment Outcome of Nab-paclitaxel Plus Gemcitabine for Leptomeningeal Carcinomatosis from Pancreatic Ductal Adenocarcinoma: An Autopsy Case Report.
A 57-year-old woman with a sudden-onset seizure was hospitalized. Brain magnetic resonance imaging findings led to a suspicion of leptomeningeal carcinomatosis (LMC) with... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34148945 | 19,505,629 | 2021-12-01 |
What was the administration route of drug 'PACLITAXEL'? | Treatment Outcome of Nab-paclitaxel Plus Gemcitabine for Leptomeningeal Carcinomatosis from Pancreatic Ductal Adenocarcinoma: An Autopsy Case Report.
A 57-year-old woman with a sudden-onset seizure was hospitalized. Brain magnetic resonance imaging findings led to a suspicion of leptomeningeal carcinomatosis (LMC) with... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34148945 | 19,505,629 | 2021-12-01 |
What was the dosage of drug 'GEMCITABINE'? | Treatment Outcome of Nab-paclitaxel Plus Gemcitabine for Leptomeningeal Carcinomatosis from Pancreatic Ductal Adenocarcinoma: An Autopsy Case Report.
A 57-year-old woman with a sudden-onset seizure was hospitalized. Brain magnetic resonance imaging findings led to a suspicion of leptomeningeal carcinomatosis (LMC) with... | 1000 MG/SQ.M EVERY EVERY 4 WEEKS | DrugDosageText | CC BY-NC-ND | 34148945 | 19,505,629 | 2021-12-01 |
What was the dosage of drug 'PACLITAXEL'? | Treatment Outcome of Nab-paclitaxel Plus Gemcitabine for Leptomeningeal Carcinomatosis from Pancreatic Ductal Adenocarcinoma: An Autopsy Case Report.
A 57-year-old woman with a sudden-onset seizure was hospitalized. Brain magnetic resonance imaging findings led to a suspicion of leptomeningeal carcinomatosis (LMC) with... | 125 MG/SQ.M | DrugDosageText | CC BY-NC-ND | 34148945 | 19,505,629 | 2021-12-01 |
What was the outcome of reaction 'Disease progression'? | Treatment Outcome of Nab-paclitaxel Plus Gemcitabine for Leptomeningeal Carcinomatosis from Pancreatic Ductal Adenocarcinoma: An Autopsy Case Report.
A 57-year-old woman with a sudden-onset seizure was hospitalized. Brain magnetic resonance imaging findings led to a suspicion of leptomeningeal carcinomatosis (LMC) with... | Fatal | ReactionOutcome | CC BY-NC-ND | 34148945 | 19,505,629 | 2021-12-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute leukaemia in remission'. | Continuous Complete Remission in Two Patients with Acute Lymphoblastic Leukemia and Severe Fungal Infection Following Short-Term, Dose-Reduced Chemotherapy.
Spontaneous remission in acute lymphoblastic leukemia (ALL) is a rare phenomenon, which typically involves a pattern of feverish or septic disease followed by quic... | CYCLOPHOSPHAMIDE, DAUNORUBICIN, DEXAMETHASONE, METHOTREXATE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34149402 | 19,495,118 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac failure'. | Continuous Complete Remission in Two Patients with Acute Lymphoblastic Leukemia and Severe Fungal Infection Following Short-Term, Dose-Reduced Chemotherapy.
Spontaneous remission in acute lymphoblastic leukemia (ALL) is a rare phenomenon, which typically involves a pattern of feverish or septic disease followed by quic... | CYCLOPHOSPHAMIDE, DAUNORUBICIN, DEXAMETHASONE, METHOTREXATE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34149402 | 19,495,118 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fungal infection'. | Continuous Complete Remission in Two Patients with Acute Lymphoblastic Leukemia and Severe Fungal Infection Following Short-Term, Dose-Reduced Chemotherapy.
Spontaneous remission in acute lymphoblastic leukemia (ALL) is a rare phenomenon, which typically involves a pattern of feverish or septic disease followed by quic... | DAUNORUBICIN, DEXAMETHASONE, MERCAPTOPURINE, METHOTREXATE, VINCRISTINE | DrugsGivenReaction | CC BY | 34149402 | 19,497,235 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemorrhage intracranial'. | Continuous Complete Remission in Two Patients with Acute Lymphoblastic Leukemia and Severe Fungal Infection Following Short-Term, Dose-Reduced Chemotherapy.
Spontaneous remission in acute lymphoblastic leukemia (ALL) is a rare phenomenon, which typically involves a pattern of feverish or septic disease followed by quic... | CYCLOPHOSPHAMIDE, DAUNORUBICIN, DEXAMETHASONE, METHOTREXATE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34149402 | 19,495,118 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mucormycosis'. | Continuous Complete Remission in Two Patients with Acute Lymphoblastic Leukemia and Severe Fungal Infection Following Short-Term, Dose-Reduced Chemotherapy.
Spontaneous remission in acute lymphoblastic leukemia (ALL) is a rare phenomenon, which typically involves a pattern of feverish or septic disease followed by quic... | CYCLOPHOSPHAMIDE, DAUNORUBICIN, DEXAMETHASONE, METHOTREXATE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34149402 | 19,495,118 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Continuous Complete Remission in Two Patients with Acute Lymphoblastic Leukemia and Severe Fungal Infection Following Short-Term, Dose-Reduced Chemotherapy.
Spontaneous remission in acute lymphoblastic leukemia (ALL) is a rare phenomenon, which typically involves a pattern of feverish or septic disease followed by quic... | CYCLOPHOSPHAMIDE, DAUNORUBICIN, DEXAMETHASONE, METHOTREXATE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34149402 | 19,495,118 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia fungal'. | Continuous Complete Remission in Two Patients with Acute Lymphoblastic Leukemia and Severe Fungal Infection Following Short-Term, Dose-Reduced Chemotherapy.
Spontaneous remission in acute lymphoblastic leukemia (ALL) is a rare phenomenon, which typically involves a pattern of feverish or septic disease followed by quic... | CYCLOPHOSPHAMIDE, DAUNORUBICIN, DEXAMETHASONE, METHOTREXATE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34149402 | 19,495,118 | 2021 |
What was the administration route of drug 'METHOTREXATE'? | Continuous Complete Remission in Two Patients with Acute Lymphoblastic Leukemia and Severe Fungal Infection Following Short-Term, Dose-Reduced Chemotherapy.
Spontaneous remission in acute lymphoblastic leukemia (ALL) is a rare phenomenon, which typically involves a pattern of feverish or septic disease followed by quic... | Intrathecal | DrugAdministrationRoute | CC BY | 34149402 | 19,495,118 | 2021 |
What was the dosage of drug 'DEXAMETHASONE'? | Continuous Complete Remission in Two Patients with Acute Lymphoblastic Leukemia and Severe Fungal Infection Following Short-Term, Dose-Reduced Chemotherapy.
Spontaneous remission in acute lymphoblastic leukemia (ALL) is a rare phenomenon, which typically involves a pattern of feverish or septic disease followed by quic... | THRICE | DrugDosageText | CC BY | 34149402 | 19,497,235 | 2021 |
What was the outcome of reaction 'Pneumonia fungal'? | Continuous Complete Remission in Two Patients with Acute Lymphoblastic Leukemia and Severe Fungal Infection Following Short-Term, Dose-Reduced Chemotherapy.
Spontaneous remission in acute lymphoblastic leukemia (ALL) is a rare phenomenon, which typically involves a pattern of feverish or septic disease followed by quic... | Recovered | ReactionOutcome | CC BY | 34149402 | 19,495,118 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bone pain'. | Prolonged Hypophosphatemia and Intensive Care After Curative Surgery of Tumor Induced Osteomalacia: A Case Report.
Rare FGF23-producing mesenchymal tumors lead to paraneoplastic tumor-induced osteomalacia (TIO) presenting with phosphate wasting, hypophosphatemia, chronic hypomineralization of the bone, fragility fractu... | INSULIN NOS, METFORMIN HYDROCHLORIDE, PIOGLITAZONE | DrugsGivenReaction | CC BY | 34149623 | 19,499,033 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Prolonged Hypophosphatemia and Intensive Care After Curative Surgery of Tumor Induced Osteomalacia: A Case Report.
Rare FGF23-producing mesenchymal tumors lead to paraneoplastic tumor-induced osteomalacia (TIO) presenting with phosphate wasting, hypophosphatemia, chronic hypomineralization of the bone, fragility fractu... | INSULIN NOS, METFORMIN HYDROCHLORIDE, PIOGLITAZONE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34149623 | 19,513,384 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.